APA

van de Loo F. A. J., van den Berg W. B., . (20020730). Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. : Rheumatic diseases clinics of North America.

Chicago

van de Loo Fons A J, van den Berg Wim B, . 20020730. Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. : Rheumatic diseases clinics of North America.

Harvard

van de Loo F. A. J., van den Berg W. B., . (20020730). Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. : Rheumatic diseases clinics of North America.

MLA

van de Loo Fons A J, van den Berg Wim B, . Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. : Rheumatic diseases clinics of North America. 20020730.